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Objective: The objective of the present study was to determine the ability of cerium oxide (CeO2) 
nanoparticles to protect against monocrotaline (MCT)-induced hepatotoxicity in a rat model.
Method: Twenty male Sprague Dawley rats were arbitrarily assigned to four groups: control 
(received saline), CeO2 (given 0.0001 nmol/kg intraperitoneally [IP]), MCT (given 10 mg/kg 
body weight IP as a single dose), and MCT + CeO2 (received CeO2 both before and after 
MCT). Electron microscopic imaging of the rat livers was carried out, and hepatic total 
glutathione (GSH), glutathione reductase (GR), glutathione peroxidase (GPX), glutathione 
S-transferase (GST), superoxide dismutase (SOD), and catalase (CAT) enzymatic activities 
were quantified.
Results: Results showed a significant MCT-induced decrease in total hepatic GSH, GPX, GR, 
and GST normalized to control values with concurrent CeO2 administration. In addition, MCT 
produced significant increases in hepatic CAT and SOD activities, which also ameliorated with 
CeO2.
Conclusions: These results indicate that CeO2 acts as a putative novel and effective hepato-
protective agent against MCT-induced hepatotoxicity.
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Introduction
A recent increase in interest in and use of bioreactive nanoparticles represents a new 
era in the intersection of nanotechnology and biotechnology. These studies have 
revealed a growing realization of the potential utility of novel environmentally benign 
technologies in diagnosis and therapeutic use in biological systems.
Most recently, cerium oxide (CeO2) nanoparticles have been tested for their ability 
to serve as free radical scavengers1,2 to provide protection against chemical, biological, 
and radiological insults that promote the production of free radicals. The chemistry of 
engineered CeO2 nanoparticles supports its potential role as a safe and effective biologi-
cal free radical scavenger or antioxidant. The intracellular CeO2 nanoparticles promote 
cell longevity and decrease toxic insults by virtue of their   antioxidant effects,3 prevent-
ing the accumulation of reactive oxygen species (ROS) and reducing the activation of 
the apoptotic response and death of the cells.4 In previous studies, CeO2 nanoparticles 
showed no toxic effect on normal breast epithelial (CRL 8798) cells and only a slight 
effect on breast cancer (MCF-7) cells at concentrations .50 nM.5   Furthermore, CeO2 
selectively conferred radioprotection to the normal cells (CRL 8798) as compared 
with the tumor cells (MCF-7).5International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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In this study, CeO2 was chosen because of its free   radical 
scavenging activity.6 The metal oxide is a nonstoichio-
metric compound with the cerium atom characterized by 
both +4 and +3 oxidation states and possesses a cubic fluorite 
  structure. Recent research using X-ray photoelectron spectros-
copy and X-ray absorption near-edge spectroscopy suggests 
that the concentration of Ce3+ relative to Ce4+ increases as 
particle size decreases, with a conservative (Ce3+) minimum 
of 6% in 6 nm nanoparticles and 1% in 10 nm particles.7 
This dual oxidation state means that these nanoparticles have 
  oxygen vacancies.8 The loss of oxygen and the reduction of 
Ce4+ to Ce3+, shown in Figure 1, are accompanied by creation 
of an oxygen vacancy. This property is responsible for the 
interesting redox chemistry exhibited by ceria nanoparticles 
and makes them attractive for catalytic applications.
Monocrotaline (MCT), a plant-derived pyrrolizidine 
alkaloid (PA), causes oxidative veno-occlusive disease of the 
liver, which is thought to be predominantly due to the hepatic 
formation of a pyrrolic metabolite. Several studies have shown 
that this metabolite may be detoxified by conjugation with the 
free radical scavenger reduced glutathione (GSH).
Human exposure occurs from consumption of contaminated 
grains, herbal teas, and medicines. Intraperitoneal (IP) injection 
of MCT in rats produced time-dependent hepatic parenchymal 
cell injury beginning at 12 h.9 Thus, the animal and human 
health risk posed by exposure to PAs is of great concern.4
To date, about 660 PAs and their N-oxide derivatives 
have been identified, and at least half are toxic.10,11 There 
are three major types of PAs: heliotridenes, retronecines, 
and otonecines. In general, many studies consider that PAs 
should be metabolized in vivo, predominantly in the liver 
through cytochrome P450 enzyme systems to form toxic 
pyrrole metabolites (Figure 2).12,13
MCT is a retronecine-type PA that is present in various 
species of leguminous Crotalaria plants. MCT exposure 
has been responsible for numerous outbreaks of poisoning 
  worldwide.14 Typically, exposed people develop hepatomegaly 
and veno-occlusive disease of the liver. In nonhuman primates 
and a variety of other species, MCT also causes pulmonary 
arterial hypertension and right ventricular   hypertrophy.15 
MCT undergoes hepatic bioactivation to the reactive pyrrole 
dehydromonocrotaline. It is believed that the release of reac-
tive dehydromonocrotaline from the liver is responsible for 
toxicity to extrahepatic organs, such as the heart and lungs. 
Dehydromonocrotaline is detoxified by conjugation with 
GSH.16 Thus, the toxicity of MCT is affected by the GSH 
status of the liver. MCT, in turn, influences the metabolism of 
GSH and related sulfur-containing compounds.17 Within 24 h 
of exposing rats to MCT or related PAs, there is a change in 
sulfur amino acid metabolism from the cysteine–taurine axis 
to the cysteine + GSH axis.17,18 Many studies report a marked 
decrease in the hepatic GSH level in rats treated with MCT 
when compared with the control group.19
Dehydromonocrotaline can alkylate cell macromolecules 
in the liver, with such alkylation probably representing the bio-
chemical basis of its toxicity.20,21 It can also be released into the 
circulation to bind covalently to macromolecules in extrahe-
patic organs.17,20 The amount of dehydromonocrotaline avail-
able for these presumably intoxicating pathways is affected 
markedly by the GSH content of the liver.22 GSH conjugates 
with dehydromonocrotaline to form glutathione dehydropyr-
rolizidine (GSDHP), a compound of much lower toxicity that 
is released in high concentration into the bile.20 Sulfur amino 
acids, such as methionine and cysteine, that elevate hepatic 
GSH content also protect against PA toxicity.23,24
Nanoparticles may offer a novel therapeutic alternative for 
scavenging environmentally elevated ROS. In this study, the 
use of nanoparticle-based antioxidants as a potential treatment 
for hepatotoxicity, which is a life-threatening problem, was 
explored. One obvious use of the nanoparticles would be for 
enhancing the performance of antioxidants. Therefore, the 
aims of this study were to design a rat model for hepatotox-
icity and to determine the extent to which rare earth CeO2 
nanoparticles safeguard against MCT-induced hepatotoxicity 
in the model.
Material and methods
This study was approved by the Committee of Scientific 
Ethics at Beni-Suef University, Egypt, and was carried out 
in accordance with its guidelines for animal use.
chemicals
MCT was purchased from Toronto Research Chemicals 
Inc. (North York, Canada) in a synthetic form (MCT 
  pyrrole, 3,8-didehydromonocrotaline; C16H21NO6). CeO2 
nanoparticles (.25 nm particle size, 10 wt% in H2O) were 
obtained from Sigma-Aldrich (St Louis, MO, USA). GSH 
and   glutathione S-transferase (GST) assay kits were obtained 
from   Sigma-Aldrich. Glutathione reductase (GR), catalase 
(CAT), glutathione peroxidase (GPX), and superoxide 
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dismutase (SOD) assay kits were purchased from Fisher 
Scientific Company (LLC, San Diego, CA, USA).
Animals
Twenty male Sprague Dawley rats (n = 5 per group; housed 
two to three per cage) were acclimated for 2 weeks prior 
to the study, at optimal temperature (22°C), light (14–10 h 
light–dark schedule), and humidity (40%–60%).
Treatment protocol
Following acclimation, rats were arbitrarily assigned to one 
of the four following treatment groups, dosed, and euthanized 
by carbon dioxide asphyxiation 24 h following final injection: 
1) control: rats in this group received a single dose of sterile 
phosphate-buffered physiological saline (PBS; 0.5 mL IP); 
2) CeO2: rats in this group received CeO2 (0.00001 mg/kg; 
0.5 mL in PBS IP) on days 1 and 3; 3) MCT: rats in this 
group received a single dose of MCT (10 mg/kg body 
weight in 0.5 mL PBS IP); and 4) MCT + CeO2: rats in this 
group received CeO2 (as before) on days 1, 3, 5, and 7 and a 
single dose of MCT (as before) on day 4. Concurrent CeO2 
(0.0001 nmol/kg in 0.5 mL PBS IP) was administered both 
before and after MCT   administration. MCT with or without 
concurrent CeO2 effects was evaluated.
hepatic cytosolic and mitochondrial 
extract preparation
The liver was rinsed with cold PBS to remove excess blood. 
Small portions of the liver from CeO2 treatment groups were 
preserved in glutaraldehyde and subjected to electron micro-
scopic examination using conventional methods. This was 
performed to ensure homogeneous distribution of ceria and to 
demonstrate no adverse effects of CeO2 alone on hepatocellular 
health and architecture. The remaining liver samples from each 
treatment group were minced in 10% (w/v) 0.1 M PBS (pH 7.4) 
and homogenized using a Teflon Homogenizer (Tissue Tearor, 
BioSpec Products Inc, Bartlesville, OK, USA). The homoge-
nate was centrifuged at 4000 rpm for 30 min at 4°C to separate 
supernatant from cellular debris. The supernatant was then used 
for the estimation of GSH, GR, GST, SOD, CAT, and GPX.
statistical analysis
Statistical analysis was carried out using GraphPad InStat 
software (version 3, ISS, Rome, Italy), and one-way analysis 
of variance followed by Tukey–Kramer multiple comparison 
post hoc test were used to establish significant differences 
between groups (see Table 1 and Table 2).
Results
Electron microscopic examination of liver samples from rats 
receiving CeO2 alone demonstrated a homogeneous intra-
hepatocellular distribution of nanoparticles (Figure 3A–C) 
without phenotypic alteration of hepatocellular architecture. 
Liver samples obtained from the CeO2 + MCT group also 
demonstrated regular intracellular distribution of nanopar-
ticles and, importantly, did not exhibit alterations in cellular 
morphology, which is likely to be due to CeO2 protection 
against MCT-elevated oxidative damage to the liver.
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Figure 2 Nomenclatures and structures of the tumorigenic retronecine-type pyrrolizidine alkaloids.13
Table 1 changes in hepatic cytosolic and mitochondrial gr, gsh, gsT, and gPX activities in different groups
Group GR (nmol/min/mL) GSH (μmol/mL) GST (nmol/min/mL) GPX (nmol/min/mL)
control 507.8 ± 27.48a 5.40 ± 0.59a 15.66 ± 1.55a 129.4 ± 17.42a
ceO2 572.9 ± 26.06a 5.49 ± 0.72a 16.85 ± 1.55a 340.9 ± 17.93b
McT 115.5 ± 4.6b 1.34 ± 0.099b   1.31 ± 0.35b 27.12 ± 1.01c
McT + ceO2 489.6 ± 19.98a 6.34 ± 0.20a   13.9 ± 2.5a 113.1 ± 16.04a
Notes: a–cDifferent superscripts indicate significance at P , 0.05. Values are expressed as means ± seM.
Abbreviations: gr, glutathione reductase; gsh, glutathione; gsT, glutathione s-transferase; gPX, glutathione peroxidase; ceO2, cerium oxide; McT, monocrotaline; 
seM, standard error of mean.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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Figure 3A shows CeO2 nanoparticles intracellularly in the 
endosomes, cytoplasm with no abnormal vaculation, and regu-
lar distribution of CeO2 within normal lysosomes. Figure 3B 
illustrates hepatocyte organelles (mitochondria) with a normal 
structure and regular distribution of CeO2 with homogenous 
size all over the cytoplasm; furthermore,   Figure 3C demon-
strates normal ribosomes (rough   endoplasmic reticulum).
changes of hepatic oxidative/
antioxidative parameters
changes in hepatic cytosolic and mitochondrial  
gsh, gr, gPXs, and gsT activities
Rats given a single dose of MCT showed a significant 
decrease in total GSH, as well as GR, GPX, and GST 
activities compared with the control group. Concurrent 
administration of CeO2 + MCT restored total GSH, GR, and 
GST activities to near control levels, suggesting that CeO2 
may serve as an effective therapy against hepatic oxidative 
  damage caused by MCT (Table 1).
Table 2 changes in hepatic cAT and sOD in different groups
Group CAT (nmol/min/mL) SOD (unit/g protein)
control 13.19 ± 0.54a 12.42 ± 0.29a
ceO2 13.20 ± 0.49a 16.21 ± 1.02a
McT 24.68 ± 0.82b 29.11 ± 0.35b
ceO2 + McT 14.16 ± 0.48a 11.59 ± 0.80a
Notes: a,bDifferent superscripts indicate significance at P , 0.05. Values are expressed 
as means ± seM.
Abbreviations: cAT, catalase; sOD, superoxide dismutase; ceO2, cerium oxide; 
McT, monocrotaline; seM, standard error of mean.
Figure  3A  1)  regular  distribution  of  cerium  oxide  (ceO2)  nanoparticles 
intracellular in the endosomes. 2) homogenous appearance of cytoplasm with no 
abnormal vaculation, original magnification ×12,500. 3) regular distribution of ceO2 
nanoparticles within normal lysosomes.
Figure 3B 1) hepatocytes organelles (mitochondria) showing normal structure. 
2) regular distribution of cerium oxide nanoparticles with homogenous size all over 
the cytoplasm, original magnification ×5000.
Figure 3C 1) even distribution of cerium oxide over the cytoplasm of the hepatocytes. 
2) Normal ribosomes (rough endoplasmic reticulum), original magnification ×8000.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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most frequently occurs.32 Increases in these enzyme activities 
  suggest a response toward increased ROS generation.33
The results obtained in this study concur with other 
studies suggesting that increased CAT and SOD (Table 2) 
are common cellular defense mechanisms against ROS and 
oxidative stressors. These enzymes are also considered to 
be sensitive biomarkers for hepatic oxidative stressors.34 
Cytosolic GSTs are found in almost all aerobic species and 
have the capacity to catalyze the conjugation of electrophilic 
compounds with GSH. GSTs were responsible for detoxifica-
tion of exogenous substances, which suggests GST as a major 
target of toxicity of exogenous substances.35
The results obtained show a marked decrease in GST activ-
ity, which highlights GST as a major cellular defense mecha-
nism against ROS.36 GR is responsible for the regeneration of 
GSH, and GPX works together with GSH in disintegrating 
hydrogen peroxide and other organic hydroperoxide.34
In this study, it was shown that the administration of MCT 
has a direct effect on the enzymes involved in the metabolism 
of GSH. The administration of MCT was found to cause a 
significant decrease in the GR and GPX activities (Table 1), 
which is confirmed by the marked fall in cytosolic and mito-
chondrial GSH levels (Table 1). In addition, a significant 
increase in GPX activity in the CeO2 group may be due to 
the antioxidant effects of CeO2 nanoparticles, which cause 
a marked increase in hepatic GPXs.
Nanotechnology is a multidisciplinary field that involves 
the design and engineering of objects ,100 nm in diameter. 
Nanoparticles constitute a new generation of free radical 
scavengers and the chemistry of engineered CeO2 nanopar-
ticles supports their potential role as biological free radical 
scavengers or antioxidants.
This study suggests that these nanoparticles may represent 
a novel therapeutic regenerative material that scavenges ROS 
caused by exogenously elevated ROS due to MCT exposure. 
When ROS are produced at high levels, cellular components 
are damaged. These ROS can positively affect biological 
systems as a defense mechanism against microorganisms 
and can act as signal transduction and transcription agents in 
development, stress responses, and programmed cell death. 
However, excessive oxidative stress arises from the strong 
cellular oxidizing potential of excess ROS, or free radicals, 
and has widespread adverse effects in multiple organ systems, 
including hepatocellular damage, increased risk of cataracts, 
cardiovascular disease, and cancer.37
CeO2 has a protective effect against radiation-induced 
oxidative damage and pneumonitis, although it has the ability 
to scavenge oxygen free radicals and ROS.37 In addition, CeO2 
changes in hepatic cAT and sOD activities
Rats given a single dose of MCT showed a significant 
increase in hepatic CAT and SOD activities compared with 
control rats; concurrent administration of CeO2 before and 
after MCT, as previously described, similarly normalized 
CAT and SOD to near control levels (Table 2).
Visual effects of systemic nanoparticle 
application on rat models
No visible toxicity was observed for the route of admin-
istration, and beneficial properties were observed for the 
nanoparticle treatments as well.
Discussion
MCT is a toxic PA that is globally distributed and found natu-
rally in arid plants such as Crotalaria spp.   Toxicity is caused 
by bioactivation of MCT in the liver to the reactive alkylating 
pyrrole dehydromonocrotaline. Such a mechanism was sug-
gested in 1968 by Mattocks25 and was recently verified with 
the isolation of dehydromonocrotaline from incubations of 
rat liver microsomes.26
Dehydromonocrotaline is released from isolated liver 
samples perfused with MCT, which is believed to contribute 
to additional extrahepatic toxicity.21 Dehydromonocrota-
line has the ability to alkylate cell macromolecules and 
causes hepatic and extrahepatic oxidative cellular damage. 
  Synthetic dehydromonocrotaline reproduces the toxicity 
of MCT.27,28
In an isolated liver, dehydromonocrotaline readily conju-
gates with GSH to form the less toxic secondary metabolite 
GSDHP,22 which is excreted in high concentrations into 
the bile. MCT (0.5 mM) also induces a 30-fold increase in 
the biliary excretion of GSH in an isolated, perfused liver, 
which depletes hepatic GSH stores.29 As a result, GSH levels 
fall in the MCT-exposed rat liver.30
Oxidative stress occurs due to an imbalance of oxidants 
and antioxidants and can be quantified by evaluation of the 
activity of a panel of antioxidant-related enzymes. GPX is 
a selenium-containing antioxidative enzyme that widely 
exists across species and can cause detoxification of toxic 
superoxide to nontoxic hydroxyl compound through chang-
ing reduced GSH to oxidant glutathione.31 CAT primarily 
exists in the peroxisomes of aerobic cells and serves to protect 
cells against the toxicity of hydrogen peroxide by catalyzing 
its decomposition into molecular oxygen and water without 
producing toxic free radicals. A recent study demonstrated 
that CAT is a classical oxidative biomarker and is the most 
abundant protein in peroxisomes, where oxidative stress International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
148
Amin et al
nanoparticles offer many active sites for free radical scaveng-
ing because of their large surface/volume ratio and also the 
mixed valence states for unique redox chemistry. A recent 
article reports SOD mimetic activity of CeO2.38 Furthermore, 
the free radical scavenging property of CeO2 nanoparticles is 
regenerative, which is not the case for other antioxidants.39 
The chemical nature of CeO2 nanoparticles, in which an autore-
generative reaction cycle (Ce3+ → Ce4+ → Ce3+) continues on 
the surface, is probably the mechanism by which the material 
gains an unprecedented free radical scavenging ability.37
CeO2 nanoparticles have been revealed to effectively 
protect mammalian cells against damage caused by increased 
ROS or nitrogen species, probably through their direct reaction 
with superoxide radicals, because each of these   materials has 
been shown to act as an effective SOD mimetic in vitro.40
Dehydromonocrotaline has the ability to alkylate cell 
macromolecules and cause hepatic and extrahepatic oxidative 
cellular damage. Synthetic dehydromonocrotaline reproduces 
the toxicity of MCT by formation of ROS.27,28
Results show that administration of CeO2 before and after 
MCT administration exerts an important protective effect 
as it corrects the oxidative stresses induced by administra-
tion of MCT. The experiments discussed here show that 
CeO2 nanoparticles were able to rescue cells from oxidative 
stress-induced cell damage in a manner that appears to be 
dependent on the structure of the particle but independent 
of its size within the 6–1000 nm range. There are three 
alternative explanations for the observation that the CeO2 
particles protect from oxidative stress.41 They may act as 
direct antioxidants, block ROS production by inhibiting a 
step in the programmed cell death pathway, or directly cause 
a low level of ROS production that rapidly induces an ROS 
defense system before the glutamate-induced cell death 
program is complete. The last is a form of preconditioning 
that could be caused by the exposure of cells to particulate 
material known to induce low levels of ROS.42
The results obtained in this study were the first to dem-
onstrate that CeO2 nanoparticles induce hepatoprotective 
biological responses and could be properly indicated by using 
a test approach such as oxidative stress.
From the current data, it can be concluded that CeO2 
could be used to modulate oxidative stress and has a 
  protecting effect against the hepatotoxicity induced by MCT 
administration.
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